Back to Article:

Should employers share potential tax burden for pharmacare?

Add a comment

Have your say on this topic! Comments that are thought to be disrespectful or offensive may be removed by our Benefits Canada admins. Thanks!

* These fields are required.
Field required
Field required
Field required

Bob T:

The poll question should not be an either/or question. The drug cost is usually the largest segment of the ER benefit program so there would be savings to the ER. At the same time, the governments would pick up a good deal of costs which have to be funded on some basis. And to be simple, it may be just an increase in the EHT rather than a new dedicated tax, we need to keep these things simple.

Thursday, July 19 at 12:13 pm | Reply

Join us on Twitter